Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the gaza strip

Medical Principles and Practice

Volumn 19, Issue 2, 2010, Pages 99-104

  Al Sallout, Rami J ^a   Sharif, Fadel A ^b  

^a MINISTRY OF HEALTH   (Canada)

^b ISLAMIC UNIVERSITY OF GAZA   (Palestine)

Author keywords

ACE; Gaza Strip; NOS3; PAI 1; Recurrent miscarriage

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; MIDDLE EAST; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 76949100676     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000273067     Document Type: Article

References (34)

1. Bremme KA: Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153-168.
2. Brenner B: Haemostatic changes in pregnancy. Thromb Res 2004; 114: 409-414.
3. Choudhury SR, Knapp LA: Human pregnancy failure: immunological factors. Hum Reprod Update 2001; 7: 113-134.
4. Kutteh W: Recurrent pregnancy loss; in Carr BR, Blackwell RE (eds): Textbook of Reproductive Medicine, ed 2. Stamford, Appleton and Lange, 1998, pp 679-692.
5. Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD: cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 1986; 78: 1673-1680.
6. Loskutoff DJ, Linders M, Keijer J, Veeman H, van Heerikhuizen H, Pannekoek H: Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns. Biochemistry 1987; 26: 3763-3768.
7. Lockshin MD: Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost 1999; 82: 641-648.
8. Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, Teisner B: Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 2000; 21: 754-762.
9. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G: Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997; 17: 2082-2087.
10. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor- 1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745.
11. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T: The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000; 49: 845-852.
12. Glueck CJ, Wang P, Fontaine RN, Sieve- Smith L, Tracy T: Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999; 48: 1589-1595.
13. Wolf CE, Haubelt H, Pauer HU, Hinney B, Krome-Cesar C, Legler TJ, Hellstern P, Emons G, Zoll B, Kohler M: Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb 2003; 33: 134-137.
14. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin Iconverting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
16. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, Marcucci R, Brunelli T, Mello G, Parretti E, Pepe G, Abbate R: Angiotensin- converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase firsttrimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 2000; 11: 657-662.
17. Zhu M, Xia Y, Cheng W: Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1998; 33: 83-85.
18. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N: Angiotensin converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J Hypertens 1999; 17: 765-768.
19. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rafjer J: Nitric oxide and cyclic GMP formation can cause electrical field stimulation that can cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843-850.
20. Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA: Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001; 22: 361-368.
21. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832-2835.
22. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999; 33: 933-936.
23. Zhang MX, Ou H, Shen YH, Wang J, Coselli J, Wang XL: Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 2005; 102: 16967-16972.
24. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169: 1316-1320.
25. Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber JC: Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod 2000; 16: 1644-1647.
26. Foka ZJ, Lambropoulos AF, Saravelos H: Factor V Leiden, prothrombin G 20210 A mutations, but not methylenetetrahydrofolate reductase C 677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15: 458-462.
27. Wizard Genomic DNA Purification Kit (modified on July 13th, 2005). www.promega. com.
28. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
29. Falk G, Almqvist A, Nordenhem A, Svensson H, Wiman B: Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170-174.
30. Bayoumi RA, Simsek M, Yahya TM, Bendict S, Al-Hinai A, Al-Barwani H, Hassan MO: Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum Biol 2006; 78: 103-108.
31. Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ: Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 2003; 18: 2473-2477.
32. Brenner B: Inherited thrombophilia and pregnancy loss (review). Thromb Haemost 1999; 82: 634-640.
33. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A: Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001; 97: 44-48.
34. Tempfer CB, Moreno RM, Gregg AR: Genetic control of fertility and embryonic waste in the mouse: a role for angiotensinogen. Biol Reprod 2000; 62: 457-462